Transplantation, Homologous
"Transplantation, Homologous" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Transplantation between individuals of the same species. Usually refers to genetically disparate individuals in contradistinction to isogeneic transplantation for genetically identical individuals.
| Descriptor ID |
D014184
|
| MeSH Number(s) |
E04.936.864
|
| Concept/Terms |
Transplantation, Homologous- Transplantation, Homologous
- Transplantation, Allogeneic
- Homografting
- Homologous Transplantation
- Allogeneic Transplantation
- Allografting
|
Below are MeSH descriptors whose meaning is more general than "Transplantation, Homologous".
Below are MeSH descriptors whose meaning is more specific than "Transplantation, Homologous".
This graph shows the total number of publications written about "Transplantation, Homologous" by people in this website by year, and whether "Transplantation, Homologous" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 4 | 4 | | 1997 | 0 | 5 | 5 | | 1998 | 0 | 4 | 4 | | 1999 | 0 | 5 | 5 | | 2000 | 1 | 5 | 6 | | 2001 | 0 | 9 | 9 | | 2002 | 1 | 9 | 10 | | 2003 | 0 | 11 | 11 | | 2004 | 3 | 4 | 7 | | 2005 | 1 | 10 | 11 | | 2006 | 3 | 7 | 10 | | 2007 | 1 | 10 | 11 | | 2008 | 0 | 10 | 10 | | 2009 | 3 | 12 | 15 | | 2010 | 1 | 19 | 20 | | 2011 | 2 | 23 | 25 | | 2012 | 1 | 11 | 12 | | 2013 | 1 | 18 | 19 | | 2014 | 1 | 9 | 10 | | 2015 | 1 | 9 | 10 | | 2016 | 1 | 13 | 14 | | 2017 | 3 | 13 | 16 | | 2018 | 1 | 20 | 21 | | 2019 | 1 | 14 | 15 | | 2020 | 0 | 14 | 14 | | 2021 | 0 | 9 | 9 | | 2022 | 0 | 7 | 7 | | 2023 | 0 | 4 | 4 | | 2024 | 0 | 3 | 3 | | 2025 | 0 | 9 | 9 | | 2026 | 0 | 8 | 8 |
To return to the timeline, click here.
Below are the most recent publications written about "Transplantation, Homologous" by people in Profiles.
-
Pidala J, Cieri N, Schell MJ, Song X, Shao Y, Cao B, Du D, Thapa R, Betts B, Janssen W, Cubitt C, Yoder S, O'Leary M, Beato F, Veerapathran A, Menges M, Burton M, Bejanyan N, Castaneda-Puglianini O, Elmariah H, Faramand R, Fernandez HF, Hansen DK, Jain M, Khimani F, Lazaryan A, Liu H, Locke F, Mirza AS, Mishra A, Nieder M, Nishihori T, Ochoa-Bayona L, Perez L, Perna F, Ramlal R, Torres-Luna N, Anasetti C. Expanded antigen-specific donor regulatory T cells for GVHD prevention. Blood. 2026 09 24; 148(13):1659-1669.
-
Negrin RS, Meyer EH. CD4+CD25+FOXP3+ regulatory T cells to protect against graft-versus-host disease. Blood. 2026 09 10; 148(11):1381-1387.
-
Rolles B, Bewersdorf JP, Kewan T, Blaha O, Stempel JM, Lanino L, Al Ali NH, DeZern AE, Sekeres MA, Uy GL, Urrutia S, Carraway HE, Desai P, Griffiths EA, Stein EM, Brunner AM, McMahon C, Shallis RM, Zeidner JF, Savona MR, Barua S, Chandhok NS, Logothetis C, Bidikian A, Getz TM, Roboz GJ, Wang ES, Harris AC, Amaya ML, Hawkins H, Ball S, Grenet J, Abedi P, Shimony S, Lindsley RC, Xie Z, Madanat YF, Abaza Y, Badar T, Haferlach T, Maciejewski JP, Sallman D, Enjeti A, Al-Rabi K, Halahleh K, Hiwase D, Diez-Campelo M, Valcarcel D, Haferlach C, Pleyer L, Kotsianidis I, Pappa V, Santini V, Consagra A, Al-Kali A, Ogawa S, Nannya Y, Porta MGD, Komrokji RS, Zeidan AM, Stahl M. Impact of Response to Hypomethylating Agent-Based Therapy on Survival Outcomes in the Context of Baseline Clinical-Molecular Risk and Transplant Status in Patients With Higher-Risk Myelodysplastic Syndromes/Neoplasms: An analysis From the International Consortium for MDS (icMDS). Am J Hematol. 2026 Nov; 101(11):2786-2798.
-
Gattinoni L, Inchingolo G, Harrer DC, Susana A, Puccio S, Slavkovic-Lukic D, Natrakul DA, Strieder N, Heuser-Loy C, Baldwin JG, Fioravanti J, Ji Y, Gautam S, Suriano C, Martín-Santos A, Schelker RC, Patel N, Mann J, Goff S, Mikkilineni L, Yang JC, Kwong MLM, Patel R, Rehli M, Highfill SL, Stroncek DF, Rosenberg SA, Biasco L, Lugli E, Brudno JN, Kochenderfer JN. Distinct in vivo dynamics of donor-derived stem cell memory CAR T cells post-allogeneic HSCT relapse. Cell. 2026 Jun 11; 189(12):3686-3700.e10.
-
Meyer EH, Salhotra A, Gandhi AP, Pantin J, Patel SS, Hoeg RT, Gomez-Arteaga A, Faramand R, Tamari R, Waller EK, Kosuri S, Jimenez Jimenez AM, Holter-Chakrabarty J, Dholaria B, Chen YB, Hamilton BK, Magenau J, Eghtedar A, Murray JM, Pavlova A, Fernhoff NB, McClellan JS, Killian MS, Li A, Negrin RS, Oliai C. Orca-T vs allogeneic hematopoietic stem cell transplantation (Precision-T): a multicenter, randomized phase 3 trial. Blood. 2026 Mar 12; 147(11):1168-1177.
-
Alexander JL, Dávila Saldaña BJ, Brazauskas R, Dammalapati SG, Griffith LM, Shah AJ, Shimano KA, Ochs HD, Bleesing JJ, Ebens CL, Kapadia M, Bauchat A, Kapoor N, Oved JH, Eissa H, Lust H, Keller MD, Haines H, Chandrakasan S, Talano JA, Rayes A, Madden L, Shereck E, Miller HK, Satter LF, Martinez C, Rozmus J, Bednarski JJ, Yu LC, Chellapandian D, Aquino VM, Knutsen A, Chong H, Chopek A, Gillio AP, Joshi A, Rangarajan H, Moore TB, Andolina JR, DeSantes KB, Vander Lugt M, Prockop SE, Shyr DC, Sullivan KE, Parikh S, Weinacht KG, Torgerson TR, Marsh R, Dvorak CC, Chan AY, Haddad E, Heimall JR, Pulsipher MA, Leiding JW, Kohn DB, Puck JM, Notarangelo LD, Rawlings DJ, Cowan MJ, Petrovic A, Pai SY, Burroughs LM. Hematopoietic cell transplantation for Wiskott-Aldrich syndrome: a PIDTC report. Blood Adv. 2026 Mar 10; 10(5):1783-1798.
-
Campa-Carranza JN, Capuani S, Willman MA, Rabassa A, Joubert AL, Bo T, Franco L, Conte M, Anaya-García AL, Rome GE, Ouni R, Seaborne HJ, Caffey CA, Berman DM, Zheng J, Paez-Mayorga J, Chua CYX, Chen SH, Kenyon NS, Grattoni A. Profiling Localized Immunomodulation and Drug Biodistribution within a Subcutaneous Vascularized Niche for Cell Transplantation. Adv Sci (Weinh). 2026 May; 13(28):e20914.
-
Wang L, Pulgrossi RC, Anderson J, Garcia A, Meyer EH, Zehnder JL, Pinsky BA. Assessing the Clinical Performance of a Presymptomatic Acute Graft-Versus-Host Disease Biomarker Test in Hematopoietic Stem Cell Transplant Recipients. J Appl Lab Med. 2026 Mar 05; 11(2):257-268.
-
Nelson SL, Hyacinth S, Aldamak B, Kopecky BJ. Vascular Remodeling in Chronic Rejection: Insights into Transplant Vasculopathy Across Solid Organ Allografts. Results Probl Cell Differ. 2026; 77:167-178.
-
Hammoudi T, Nucera S, Troullioud Lucas AG, Ansari M, Balduzzi A, Bertaina A, Buechner J, Corbacioglu S, Dalle JH, Kalwak K, Lee D, Levine JE, Lindemans CA, Locatelli F, Meisel R, Nierkens S, Ottaviano G, Perez-Martinez A, Pichler H, Prockop SE, Pulsipher MA, Talano JM, Tewari S, Schultz KR, Shah NN, Verneris MR, Boelens JJ. Harmonized immune recovery monitoring after HCT: evidence and practical guidance from the Westhafen Intercontinental Group. Blood Adv. 2025 Dec 09; 9(23):6141-6157.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|